Arena Capital Advisors’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-83,299
Closed -$817K 323
2022
Q1
$817K Sell
83,299
-121,406
-59% -$1.18M 0.12% 124
2021
Q4
$2M Hold
204,705
0.18% 145
2021
Q3
$1.99M Buy
204,705
+30,423
+17% +$295K 0.16% 158
2021
Q2
$1.69M Buy
+174,282
New +$1.7M 0.14% 189

Other funds holding SSAA

Arena Capital Advisors's SSAA Position: Q2 2022 in Review

Arena Capital Advisors sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q2 2022, closing a stake of 83,299 shares — an estimated $817K sold.

Arena Capital Advisors first reported a position in SSAA in Q2 2021 and held it in 4 quarters. The position peaked at $2M in Q4 2021. 88 funds tracked by Wall St. Rank hold SSAA as of Q2 2022.

  • Arena Capital Advisors reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Arena Capital Advisors sold 83,299 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q2 2022, an estimated $817K.
  • Arena Capital Advisors first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 4 quarters.
  • Arena Capital Advisors's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $2M in Q4 2021.
  • 88 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q2 2022.

Based on Arena Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.